A detailed history of Strategic Blueprint, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Blueprint, LLC holds 11,563 shares of LLY stock, worth $9.2 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
11,563
Previous 12,026 3.85%
Holding current value
$9.2 Million
Previous $10.9 Million 5.91%
% of portfolio
0.69%
Previous 0.79%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $357,500 - $444,489
-463 Reduced 3.85%
11,563 $10.2 Million
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $94,957 - $119,084
-131 Reduced 1.08%
12,026 $10.9 Million
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $25,464 - $34,068
-43 Reduced 0.35%
12,157 $9.46 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $46,741 - $55,102
89 Added 0.73%
12,200 $7.11 Million
Q3 2023

Oct 18, 2023

SELL
$434.7 - $599.3 $117,803 - $162,410
-271 Reduced 2.19%
12,111 $6.51 Million
Q2 2023

Oct 18, 2023

BUY
$350.74 - $468.98 $2.49 Million - $3.33 Million
7,103 Added 134.55%
12,382 $5.81 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $178,922 - $210,136
576 Added 12.25%
5,279 $1.81 Million
Q4 2022

Jan 26, 2023

SELL
$321.55 - $374.67 $168,170 - $195,952
-523 Reduced 10.01%
4,703 $0
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $15,713 - $17,907
53 Added 1.02%
5,226 $1.69 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $174,206 - $204,543
625 Added 13.74%
5,173 $1.68 Million
Q1 2022

Aug 12, 2022

BUY
$234.69 - $291.66 $56,325 - $69,998
240 Added 5.57%
4,548 $1.3 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $295,003 - $366,100
1,312 Added 43.79%
4,308 $1.19 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $29,029 - $35,725
131 Added 4.57%
2,996 $692,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $40,623 - $52,546
225 Added 8.52%
2,865 $657,000
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $40,258 - $52,116
-245 Reduced 8.49%
2,640 $493,000
Q4 2020

Jan 26, 2021

BUY
$130.46 - $172.63 $37,442 - $49,544
287 Added 11.05%
2,885 $487,000
Q3 2020

Oct 27, 2020

BUY
$146.22 - $169.13 $79,689 - $92,175
545 Added 26.55%
2,598 $385,000
Q2 2020

Jul 20, 2020

BUY
$136.42 - $164.18 $280,070 - $337,061
2,053 New
2,053 $337,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.